Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Department of Histology and Embryology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, China.
Acta Biochim Biophys Sin (Shanghai). 2018 Jun 1;50(6):560-566. doi: 10.1093/abbs/gmy038.
Autoantibodies against angiotensin II Type 1 receptor (AT1-AA) are routinely detected in the serum of preeclampsia patients, which results in an increase in vascular tone and an elevation in intracellular calcium concentration of rat vascular smooth muscle (VSM). The big conductance calcium-activated potassium channels (BKCa channels) account for the dominant outward currents in VSMCs, contributing to membrane hyperpolarization and vasodilation. In the present study, we investigated the effect of AT1-AA on BKCa channels. A preeclampsia model was established by passively immunizing healthy pregnant BALB/c mice with AT1-AA extracted from hybridoma culture supernatant. Blood pressure, serum AT1-AA levels, and urinary protein were measured in the immunized mice. BKCa channel expression was detected using qRT-PCR and immunohistochemical technique. The patch-clamp technique was used to record the single currents of BKCa channels in the HEK293T cells that had been transfected. AT1-AA immunized mice exhibited elevated AT1-AA and urinary protein levels compared with mice of the vehicle group. Systolic blood pressure was also increased in the immunized group. BKCa channel β1-subunit expression was reduced in the mesenteric arteries of immunized mice. AT1-AA could inhibit the BKCa currents and the inhibitory effects were not completely reversed following the application of valsartan, an inhibitor of AT1 receptor. In conclusion, AT1-AA could decrease BKCa expression and inhibit BKCa activity independent of AT1R. These inhibitory effects are likely to be contributory factors in the promotion of increased vascular tone caused by AT1-AA in preeclampsia.
抗血管紧张素 II 型 1 型受体 (AT1-AA) 自身抗体通常在先兆子痫患者的血清中被检测到,这导致血管张力增加和大鼠血管平滑肌 (VSM) 细胞内钙离子浓度升高。大电导钙激活钾通道 (BKCa 通道) 构成 VSMCs 中的主要外向电流,有助于膜超极化和血管舒张。在本研究中,我们研究了 AT1-AA 对 BKCa 通道的影响。通过用从杂交瘤培养上清液中提取的 AT1-AA 被动免疫健康妊娠 BALB/c 小鼠来建立先兆子痫模型。测量免疫小鼠的血压、血清 AT1-AA 水平和尿蛋白。使用 qRT-PCR 和免疫组织化学技术检测 BKCa 通道表达。使用膜片钳技术记录转染的 HEK293T 细胞中 BKCa 通道的单电流。与载体组相比,AT1-AA 免疫小鼠的 AT1-AA 和尿蛋白水平升高,免疫组的收缩压也升高。免疫小鼠的肠系膜动脉中 BKCa 通道 β1 亚基表达减少。AT1-AA 可抑制 BKCa 电流,而 AT1 受体抑制剂缬沙坦不能完全逆转抑制作用。总之,AT1-AA 可降低 BKCa 的表达并抑制 BKCa 活性,而不依赖于 AT1R。这些抑制作用可能是 AT1-AA 在先兆子痫中引起血管张力增加的促进因素之一。